Search Results - "Leiter, Madeline"
-
1
Improved Dosing and Administration of Rivaroxaban when Prescribed by a Cardiologist
Published in Heart international (01-01-2019)“…Rivaroxaban is a direct oral anticoagulant (DOAC) indicated to reduce risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation…”
Get full text
Journal Article -
2
EVALUATION OF RIVAROXABAN ADMINISTRATION FOR ATRIAL FIBRILLATION IN A CARDIOLOGY PRACTICE
Published in Journal of the American College of Cardiology (10-03-2018)“…Background Rivaroxaban (Xarelto) is a direct oral anticoagulant (DOAC) indicated to reduce risk of stroke and systemic embolism in patients with non-valvular…”
Get full text
Journal Article